Gene: RALY
Official Full Name: RALY heterogeneous nuclear ribonucleoproteinprovided by HGNC
Gene Summary: This gene encodes a member of the heterogeneous nuclear ribonucleoprotein (hnRNP) gene family. This protein may play a role in pre-mRNA splicing and in embryonic development. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Sep 2011]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO30138 | RALY Knockout cell line (HeLa) | Human | RALY | 1:3~1:6 | Negative | Online Inquiry |
KO30139 | RALY Knockout cell line (HCT 116) | Human | RALY | 1:2~1:4 | Negative | Online Inquiry |
KO30140 | RALY Knockout cell line (HEK293) | Human | RALY | 1:3~1:6 | Negative | Online Inquiry |
KO30141 | RALY Knockout cell line (A549) | Human | RALY | 1:3~1:4 | Negative | Online Inquiry |
RALY Gene Knockout Cell Lines are a sophisticated biological tool designed for advanced genomic research, particularly in the study of gene function and regulation. These cell lines have been engineered to express a precise genomic deletion of the RALY gene, a critical component in the post-transcriptional regulation of RNA, which implicates its potential role in various biological processes and diseases, including cancer and neurodegeneration.
The key mechanism by which RALY Gene Knockout Cell Lines operate involves the elimination of RALY protein expression, providing researchers the opportunity to examine the consequences of RALY deficiency on cellular processes such as mRNA stability, translation control, and stress responses. This model allows for a comprehensive investigation into the pathways influenced by RALY, thereby enhancing our understanding of gene regulation mechanisms and their implications in cellular physiology.
Scientifically, these knockout cell lines hold significant value in both research and clinical settings. They serve as powerful platforms for functional genomics studies, drug discovery, and the elucidation of disease mechanisms, thereby facilitating the development of targeted therapies and tailored treatment strategies. Researchers can utilize these cell lines to dissect complex biological networks and validate potential therapeutic targets.
Compared to alternative models, RALY Gene Knockout Cell Lines offer unparalleled specificity and reliability. Their curated design minimizes off-target effects, allowing for robust data generation and accurate interpretation. Additionally, they can be utilized with standard assays and experimental paradigms, ensuring seamless integration into existing workflows.
For researchers and clinicians seeking to unravel the complexities of gene function and its impact on human health, RALY Gene Knockout Cell Lines represent an invaluable resource that can significantly accelerate scientific discovery. With our strong commitment to quality and innovation, our company leverages cutting-edge technologies to produce superior biological products that empower scientific advancement.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.